Levothyroxine Recall: Macleods 150 mcg Rx Only 1000-tablet bottle
Announced 2026-04-01 · FDA
The FDA is recalling Levothyroxine Sodium Tablets USP 150 mcg, 1000-tablet bottle (Rx Only) distributed nationwide. The affected lot is Lot 16240062A, exp 3/2026, manufactured by Macleods Pharmaceuticals Ltd. in India for Macleods Pharma USA, Inc. The reason is a subpotent drug and the recall severity is moderate.
| Brand | MACLEODS PHARMA USA, INC |
|---|---|
| Product | Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44 |
| Reason | Subpotent Drug |
| Severity | moderate |
| Units affected | 1315 |
| Distribution | Nationwide |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any tablets from Lot 16240062A.
- Contact your healthcare provider or pharmacist to arrange a replacement or refund and discuss disposal.
- If you have the recalled lot, return to the pharmacy or follow local disposal guidelines; keep the bottle for reference.
How to identify the recalled item
| Lot / date codes | Lot 16240062A, exp date 3/2026 |
|---|---|
| Lot / date codes | Lot 16240062A, exp date 3/2026 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other levothyroxine recalls
- Levothyroxine Recall: Thyro-Tabs 150mcg · 2026-01-21
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.